Search

Author/Creator Ganguly, Bishu

1. The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to Zenapax®. Issue 7 (2nd October 2016)

Authors:
Ganguly, Bishu; Balasa, Balaji; Efros, Lyubov; Hinton, Paul R.; Hartman, Stephen; Thakur, Archana; Xiong, Joanna M.; Schmidt, Brian; Robinson, Randy R.; Sornasse, Thierry; Vexler, Vladimir; Sheridan, James P.
Journal:
MAbs
Issue:
Volume 8:Issue 7(2016)
Page Start:
1417
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Use of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulator. (2nd November 2016)

Authors:
Williams, Daphne; Tao, Xiaolu; Zhu, Lili; Stonier, Michele; Lutz, Justin D.; Masson, Eric; Zhang, Sean; Ganguly, Bishu; Tzogas, Zoe; Lubin, Susan; Murthy, Bindu
Journal:
British journal of clinical pharmacology
Issue:
Volume 83:Number 2(2017:Feb.)
Page Start:
370
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search